Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial

OBJECTIVE: We investigated the association between obesity and biomarkers indicating cardiac or renal dysfunction or inflammation and their interaction with obesity and outcomes. METHODS: A total of 14 753 patients in the Apixaban for Reduction In STroke and Other ThromboemboLic Events in Atrial Fib...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandhu, Roopinder K, Ezekowitz, Justin A, Hijazi, Ziad, Westerbergh, Johan, Aulin, Julia, Alexander, John H, Granger, Christopher B, Halvorsen, Sigrun, Hanna, Michael S, Lopes, Renato D, Siegbahn, Agneta, Wallentin, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Arrhythmias and Sudden Death
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242013/
https://www.ncbi.nlm.nih.gov/pubmed/30487982
http://dx.doi.org/10.1136/openhrt-2018-000908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242013/
https://www.ncbi.nlm.nih.gov/pubmed/30487982
http://dx.doi.org/10.1136/openhrt-2018-000908

Ejemplares similares